private:oncobox
|
18043403
|
Apr 14th, 2024 12:00AM
|
Oncobox
|
130
|
2.00
|
Open
|
|
Apr 14th, 2024 05:00AM
|
Apr 14th, 2024 05:00AM
|
Oncobox is transforming cancer care with precision medicine by leveraging the power of artificial intelligence and systems biology. Through the integration of deep molecular profiling—which includes analysis of not only DNA mutations (exome) but also RNA gene expression (transcriptome)—and comprehensive data analytics, we achieve unmatched precision in identifying the most effective treatment strategies, markedly improving outcomes for patients battling late-stage cancers.
The effectiveness of Oncobox's technology is backed by both prospective and retrospective studies. This approach has shown remarkable success, leading to a twofold decrease in disease progression and a significant increase in progression-free survival (PFS). Oncobox's innovative use of deep molecular profiling is setting new standards in the precision and efficacy of cancer treatment.
|
Open
|
biomedicine, cancer, diagnostics, and bioinformatics
|
Open
|
|
San Francisco
|
California
|
US
|
|
|
Oncobox
|
|
|
private:oncobox
|
18043403
|
Apr 13th, 2024 12:00AM
|
Oncobox
|
130
|
2.00
|
Open
|
|
Apr 13th, 2024 03:54AM
|
Apr 13th, 2024 03:58PM
|
Oncobox is transforming cancer care with precision medicine by leveraging the power of artificial intelligence and systems biology. Through the integration of deep molecular profiling—which includes analysis of not only DNA mutations (exome) but also RNA gene expression (transcriptome)—and comprehensive data analytics, we achieve unmatched precision in identifying the most effective treatment strategies, markedly improving outcomes for patients battling late-stage cancers.
The effectiveness of Oncobox's technology is backed by both prospective and retrospective studies. This approach has shown remarkable success, leading to a twofold decrease in disease progression and a significant increase in progression-free survival (PFS). Oncobox's innovative use of deep molecular profiling is setting new standards in the precision and efficacy of cancer treatment.
|
Open
|
biomedicine, cancer, diagnostics, and bioinformatics
|
Open
|
|
San Francisco
|
California
|
US
|
|
|
Oncobox
|
|
|
private:oncobox
|
18043403
|
Apr 12th, 2024 12:00AM
|
Oncobox
|
130
|
2.00
|
Open
|
|
Apr 12th, 2024 04:06AM
|
Apr 12th, 2024 01:05PM
|
Oncobox is transforming cancer care with precision medicine by leveraging the power of artificial intelligence and systems biology. Through the integration of deep molecular profiling—which includes analysis of not only DNA mutations (exome) but also RNA gene expression (transcriptome)—and comprehensive data analytics, we achieve unmatched precision in identifying the most effective treatment strategies, markedly improving outcomes for patients battling late-stage cancers.
The effectiveness of Oncobox's technology is backed by both prospective and retrospective studies. This approach has shown remarkable success, leading to a twofold decrease in disease progression and a significant increase in progression-free survival (PFS). Oncobox's innovative use of deep molecular profiling is setting new standards in the precision and efficacy of cancer treatment.
|
Open
|
biomedicine, cancer, diagnostics, and bioinformatics
|
Open
|
|
San Francisco
|
California
|
US
|
|
|
Oncobox
|
|
|
private:oncobox
|
18043403
|
Apr 11th, 2024 12:00AM
|
Oncobox
|
130
|
2.00
|
Open
|
|
Apr 11th, 2024 06:09AM
|
Apr 11th, 2024 03:44PM
|
Oncobox is transforming cancer care with precision medicine by leveraging the power of artificial intelligence and systems biology. Through the integration of deep molecular profiling—which includes analysis of not only DNA mutations (exome) but also RNA gene expression (transcriptome)—and comprehensive data analytics, we achieve unmatched precision in identifying the most effective treatment strategies, markedly improving outcomes for patients battling late-stage cancers.
The effectiveness of Oncobox's technology is backed by both prospective and retrospective studies. This approach has shown remarkable success, leading to a twofold decrease in disease progression and a significant increase in progression-free survival (PFS). Oncobox's innovative use of deep molecular profiling is setting new standards in the precision and efficacy of cancer treatment.
|
Open
|
biomedicine, cancer, diagnostics, and bioinformatics
|
Open
|
|
San Francisco
|
California
|
US
|
|
|
Oncobox
|
|
|
private:oncobox
|
18043403
|
Apr 10th, 2024 12:00AM
|
Oncobox
|
130
|
2.00
|
Open
|
|
Apr 10th, 2024 03:54AM
|
Apr 10th, 2024 09:45PM
|
Oncobox is transforming cancer care with precision medicine by leveraging the power of artificial intelligence and systems biology. Through the integration of deep molecular profiling—which includes analysis of not only DNA mutations (exome) but also RNA gene expression (transcriptome)—and comprehensive data analytics, we achieve unmatched precision in identifying the most effective treatment strategies, markedly improving outcomes for patients battling late-stage cancers.
The effectiveness of Oncobox's technology is backed by both prospective and retrospective studies. This approach has shown remarkable success, leading to a twofold decrease in disease progression and a significant increase in progression-free survival (PFS). Oncobox's innovative use of deep molecular profiling is setting new standards in the precision and efficacy of cancer treatment.
|
Open
|
biomedicine, cancer, diagnostics, and bioinformatics
|
Open
|
|
San Francisco
|
California
|
US
|
|
|
Oncobox
|
|
|
private:oncobox
|
18043403
|
Apr 9th, 2024 12:00AM
|
Oncobox
|
130
|
2.00
|
Open
|
|
Apr 9th, 2024 04:21AM
|
Apr 9th, 2024 02:30PM
|
Oncobox is transforming cancer care with precision medicine by leveraging the power of artificial intelligence and systems biology. Through the integration of deep molecular profiling—which includes analysis of not only DNA mutations (exome) but also RNA gene expression (transcriptome)—and comprehensive data analytics, we achieve unmatched precision in identifying the most effective treatment strategies, markedly improving outcomes for patients battling late-stage cancers.
The effectiveness of Oncobox's technology is backed by both prospective and retrospective studies. This approach has shown remarkable success, leading to a twofold decrease in disease progression and a significant increase in progression-free survival (PFS). Oncobox's innovative use of deep molecular profiling is setting new standards in the precision and efficacy of cancer treatment.
|
Open
|
biomedicine, cancer, diagnostics, and bioinformatics
|
Open
|
|
San Francisco
|
California
|
US
|
|
|
Oncobox
|
|
|
private:oncobox
|
18043403
|
Apr 8th, 2024 12:00AM
|
Oncobox
|
130
|
2.00
|
Open
|
|
Apr 8th, 2024 04:52AM
|
Apr 8th, 2024 04:52AM
|
Oncobox is transforming cancer care with precision medicine by leveraging the power of artificial intelligence and systems biology. Through the integration of deep molecular profiling—which includes analysis of not only DNA mutations (exome) but also RNA gene expression (transcriptome)—and comprehensive data analytics, we achieve unmatched precision in identifying the most effective treatment strategies, markedly improving outcomes for patients battling late-stage cancers.
The effectiveness of Oncobox's technology is backed by both prospective and retrospective studies. This approach has shown remarkable success, leading to a twofold decrease in disease progression and a significant increase in progression-free survival (PFS). Oncobox's innovative use of deep molecular profiling is setting new standards in the precision and efficacy of cancer treatment.
|
Open
|
biomedicine, cancer, diagnostics, and bioinformatics
|
Open
|
|
San Francisco
|
California
|
US
|
|
|
Oncobox
|
|
|
private:oncobox
|
18043403
|
Apr 7th, 2024 12:00AM
|
Oncobox
|
130
|
2.00
|
Open
|
|
Apr 7th, 2024 04:29AM
|
Apr 7th, 2024 04:29AM
|
Oncobox is transforming cancer care with precision medicine by leveraging the power of artificial intelligence and systems biology. Through the integration of deep molecular profiling—which includes analysis of not only DNA mutations (exome) but also RNA gene expression (transcriptome)—and comprehensive data analytics, we achieve unmatched precision in identifying the most effective treatment strategies, markedly improving outcomes for patients battling late-stage cancers.
The effectiveness of Oncobox's technology is backed by both prospective and retrospective studies. This approach has shown remarkable success, leading to a twofold decrease in disease progression and a significant increase in progression-free survival (PFS). Oncobox's innovative use of deep molecular profiling is setting new standards in the precision and efficacy of cancer treatment.
|
Open
|
biomedicine, cancer, diagnostics, and bioinformatics
|
Open
|
|
San Francisco
|
California
|
US
|
|
|
Oncobox
|
|
|
private:oncobox
|
18043403
|
Apr 6th, 2024 12:00AM
|
Oncobox
|
130
|
2.00
|
Open
|
|
Apr 6th, 2024 04:09AM
|
Apr 6th, 2024 04:09AM
|
Oncobox is transforming cancer care with precision medicine by leveraging the power of artificial intelligence and systems biology. Through the integration of deep molecular profiling—which includes analysis of not only DNA mutations (exome) but also RNA gene expression (transcriptome)—and comprehensive data analytics, we achieve unmatched precision in identifying the most effective treatment strategies, markedly improving outcomes for patients battling late-stage cancers.
The effectiveness of Oncobox's technology is backed by both prospective and retrospective studies. This approach has shown remarkable success, leading to a twofold decrease in disease progression and a significant increase in progression-free survival (PFS). Oncobox's innovative use of deep molecular profiling is setting new standards in the precision and efficacy of cancer treatment.
|
Open
|
biomedicine, cancer, diagnostics, and bioinformatics
|
Open
|
|
San Francisco
|
California
|
US
|
|
|
Oncobox
|
|
|
private:oncobox
|
18043403
|
Apr 5th, 2024 12:00AM
|
Oncobox
|
130
|
2.00
|
Open
|
|
Apr 5th, 2024 06:47AM
|
Apr 5th, 2024 06:47AM
|
Oncobox is transforming cancer care with precision medicine by leveraging the power of artificial intelligence and systems biology. Through the integration of deep molecular profiling—which includes analysis of not only DNA mutations (exome) but also RNA gene expression (transcriptome)—and comprehensive data analytics, we achieve unmatched precision in identifying the most effective treatment strategies, markedly improving outcomes for patients battling late-stage cancers.
The effectiveness of Oncobox's technology is backed by both prospective and retrospective studies. This approach has shown remarkable success, leading to a twofold decrease in disease progression and a significant increase in progression-free survival (PFS). Oncobox's innovative use of deep molecular profiling is setting new standards in the precision and efficacy of cancer treatment.
|
Open
|
biomedicine, cancer, diagnostics, and bioinformatics
|
Open
|
|
San Francisco
|
California
|
US
|
|
|
Oncobox
|
|
|